ロード中...
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit
BACKGROUND: The treatment effect in survival analysis is commonly quantified as the hazard ratio, and tested statistically using the standard log-rank test. Modern anticancer immunotherapies are successful in a proportion of patients who remain alive even after a long-term follow-up. This new phenom...
保存先:
| 出版年: | J Natl Cancer Inst |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855951/ https://ncbi.nlm.nih.gov/pubmed/30838402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|